Your browser doesn't support javascript.
loading
2015 European guideline on the management of Chlamydia trachomatis infections.
Lanjouw, E; Ouburg, S; de Vries, H J; Stary, A; Radcliffe, K; Unemo, M.
Afiliación
  • Lanjouw E; Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Ouburg S; Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands.
  • de Vries HJ; Department of Dermatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands STI Outpatient Clinic, Infectious Disease Cluster, Health Service Amsterdam, Amsterdam, The Netherlands Center for Infection and Immunology Amsterdam (CINIMA), Academic Medical Center (AMC), Unive
  • Stary A; Outpatients' Centre for Infectious Venereodermatological Diseases, Vienna, Austria.
  • Radcliffe K; University Hospital Birmingham Foundation NHS Trust, Birmingham, United Kingdom.
  • Unemo M; WHO Collaborating Center for Gonorrhoea and other Sexually Transmitted Infections, National Reference Laboratory for Pathogenic Neisseria, Department of Laboratory Medicine, Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden magnus.unemo@regionorebrolan.se.
Int J STD AIDS ; 27(5): 333-48, 2016 Apr.
Article en En | MEDLINE | ID: mdl-26608577
Chlamydia trachomatis infections, which most frequently are asymptomatic, are major public health concerns globally. The 2015 European C. trachomatis guideline provides: up-to-date guidance regarding broader indications for testing and treatment of C. trachomatis infections; a clearer recommendation of using exclusively-validated nucleic acid amplification tests for diagnosis; advice on (repeated) C. trachomatis testing; the recommendation of increased testing to reduce the incidence of pelvic inflammatory disease and prevent exposure to infection; and recommendations to identify, verify and report C. trachomatis variants. Improvement of access to testing, test performance, diagnostics, antimicrobial treatment and follow-up of C. trachomatis patients are crucial to control its spread. For detailed background, evidence base and discussions, see the background review for the present 2015 European guideline on the management of Chlamydia trachomatis infections (Lanjouw E, et al. Int J STD AIDS. 2015).
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Chlamydia / Chlamydia trachomatis / Técnicas de Laboratorio Clínico / Manejo de la Enfermedad / Técnicas de Amplificación de Ácido Nucleico Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Int J STD AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Chlamydia / Chlamydia trachomatis / Técnicas de Laboratorio Clínico / Manejo de la Enfermedad / Técnicas de Amplificación de Ácido Nucleico Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Límite: Female / Humans País/Región como asunto: Europa Idioma: En Revista: Int J STD AIDS Asunto de la revista: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido